• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dymax launches 1045-M adhesive for drug delivery devices

April 5, 2023 By Sean Whooley

Dymax MD 1045-M adhesive for drug delivery devices
[Image courtesy of Dymax]
Dymax announced today that it released its 1045-M adhesive, the latest product in its line of MD light-curable materials for medical device assembly.

Torrington, Connecticut-based Dymax designed MD 1045-M to bond glass, SS, ABS and PC substrates. Uses for these include assembling prefilled syringes and single-use devices. They also aid in the assembly of auto, pen and wearable injectors. The company formulated MD 1045-M to solve the challenges associated with needle orientation, material overflow and long cure times.

This low-extractable material passes ISO 10993 cytotoxicity testing and meets essential biocompatibility standards for medical device applications. Dymax aims for it to help manufacturers increase productivity, reduce processing times and exceed critical pull force and quality requirements.

The one-part, solvent-free, 100% solid adhesive represents an eco-friendly alternative to solvent-based adhesives. It features low, 475 centipoise viscosity for easy flow onto components in 10 seconds. Dymax says the current standard comes in at 30 seconds or more.

It also cures tack-free with UV/broad spectrum light. MD 1045-M is LED-curable at 365 nm in five seconds or faster for environmentally friendly processing. The low-shrinkage adhesive exhibits a glass-like cure surface and resists yellowing. It withstands autoclave cleaning and Gamma and ETO sterilization methods.

Filed Under: Auto-injectors, Drug-Device Combinations Tagged With: Dymax

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS